韩国单剂水痘疫苗接种二十年:免疫衰减、年龄偏移与成人负担上升
研究分析韩国维持单剂水痘疫苗高覆盖率二十年的免疫学、流行病学与医疗费用后果,发现医务人员中免疫衰减、青少年与成人发病率上升及成人水痘脑膜炎比例和医疗费用占比显著增加,提示需重新评估单剂接种程序。
要点
- 1990-1994年出生医务人员血清阴性率最高(调整OR 3.83),提示免疫衰减。
- 2024年青少年首次超过10岁以下儿童成为病例占比最大群体。
- 青少年和成人发病率分别增加约9倍和3倍,儿童不变。
核心结论
- 持续二十年单剂高覆盖率后出现免疫衰减、年龄偏移和成人疾病负担上升,支持重新评估单剂接种程序。
研究设计与样本
- 分析3765名医务人员水痘-带状疱疹病毒IgG滴度(按出生组),并结合2010-2024年全国监测与保险索赔数据。
主要发现
- 1990-1994年出生医务人员血清阴性率最高(调整OR 3.83)。
- 几何平均滴度随出生组递降(2000-2004 vs 1980前:GMR 0.70,95%CI 0.63-0.77)。
- 2024年青少年首次成为病例占比最大群体。
- 青少年和成人年龄别发病率分别增加约9倍和3倍,儿童不变。
- 成人水痘脑膜炎病例占比从16.4%升至72.9%,医疗费用占比从21.2%升至41.9%。
关键数值与推荐
- 单剂国家免疫规划自2005年起维持>95%覆盖率,但发病率未如预期下降。
临床怎么用
- 在尚未采用普遍水痘疫苗接种的地区,应关注年龄偏移和疾病严重度变化。
- 需重新评估单剂水痘疫苗接种程序的免疫效果与成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many countries have not adopted universal varicella vaccination (UVV), citing concerns that it could shift disease burden toward older, higher-risk age groups and be insufficiently cost-effective. Long-term data under sustained single-dose vaccination remain scarce. We assessed the immunological, epidemiological, and healthcare cost consequences of two decades of South Korea's single-dose National Immunization Program, which has maintained >95% coverage since 2005 without the anticipated decline in incidence. METHODS: We analyzed varicella-zoster virus immunoglobulin G titers in 3765 healthcare personnel (HCP) by birth group. We also examined national surveillance (Korea Disease Control and Prevention Agency) and insurance claims (Health Insurance Review and Assessment Service) data from 2010 to 2024. RESULTS: Seronegativity was highest among HCP born during 1990-1994 (adjusted odds ratio, 3.83), and geometric mean titers declined across successive birth groups (geometric mean ratio, 0.70 [95% confidence interval, 0.63-0.77], 2000-2004 vs. pre-1980), indicating waning immunity. In 2024, adolescents surpassed children aged <10 years as the largest proportion of cases for the first time. Age-specific incidence rates increased approximately ninefold in adolescents and threefold in adults while remaining unchanged in children. Among adults, the proportion of varicella meningitis cases rose from 16.4% to 72.9%, and their share of varicella-related healthcare costs rose from 21.2% to 41.9%. CONCLUSIONS: After two decades of sustained high single-dose coverage, these findings provide evidence relevant to concerns about age shift and disease severity in settings yet to adopt UVV and support reassessment of the single-dose schedule.
引用
- Park SY, Huh HJ, Choi S, et al. Waning immunity, an age shift, and rising adult burden of varicella after two decades of single-dose vaccination in South Korea. Vaccine. 2026. PMID: 42879902. doi:10.1016/j.vaccine.2026.129240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。